|
Match
|
Document |
Document Title |
|
|
US20090286750 |
USE OF RIBOSE IN LESSENING THE CLINICAL SYMPTOMS OF ABERRANT FIRING OF NEURONS
A method for treating a mammal suffering from a condition caused by aberrant neuron firing is disclosed herein. The method includes administering (e.g., orally administering) to the mammal (e.g., a...
|
|
|
US20090286749 |
Cosmetic Composition and a Process For Preparing Said Composition
The present invention relates to a cosmetic composition that provides prolonged moisturizing to the skin and a differentiated sensorial, and may be employed in various types of products. This...
|
|
|
US20090281046 |
Cyclopropanated Carbohydrates
Disclosed are cyclopropanated carbohydrate compounds of formulas I and II:
Also disclosed are methods of treating or preventing a central nervous system ailment by administering to an organism...
|
|
|
US20090280105 |
Novel Fungal Enzymes
This invention relates to novel enzymes and novel methods for producing the same. More specifically this invention relates to a variety of fungal enzymes. Nucleic acid molecules encoding such...
|
|
|
US20090274769 |
HEALING COMPOSITION
The invention relates to a ternary composition characterized in that it consists of a source of carbohydrates, a source of divided minerals, chosen from clays, and a source of fatty acids. It also...
|
|
|
US20090274638 |
COSMETIC USE OF A C-GLYCOSIDE DERIVATIVE IN COMBINATION WITH ASCORBIC ACID
The present invention relates to a cosmetic use of a synergistic combination of at least one C-glycoside derivative with at least ascorbic acid, or one of its derivatives or analogs, for...
|
|
|
US20090269426 |
COMBINATIONS OF VASOACTIVE AGENTS AND THEIR USE IN THE TREATMENT OF SEXUAL DYSFUNCTIONS
This invention relates to combinations of vasoactive substances which are useful in the treatment of sexual dysfunctions associated with poor local blood supply and/or insufficient lubrication. The...
|
|
|
US20090264375 |
INTRAOCULAR IRRIGATING SOLUTIONS AND METHODS FOR TREATING CORNEAL EDEMA
One aspect of the present invention relates to methods of treating corneal edema comprising contacting a cornea with an ophthalmic irrigating composition comprising histidine. In certain...
|
|
|
US20090264374 |
UTILIZATION OF ANTI-NEUROPATHIC PAIN EFFECT OF D-ALLOSE AND D-PSICOSE
[PROBLEMS] To control neuropathic pain produced by various mechanisms. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition for elimination, relief or reduction of neuropathic pain comprising,...
|
|
|
US20090264337 |
Cellular GPRS-communication linked glucometer - pedometer
The Cellular GPRS system includes a cellular-based Glucometer (CBG) for blood glucose monitoring, a pedometer for exertion measurement, combined with user-entered dietary or other diabetes-relevant...
|
|
|
US20090257998 |
METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS
The common link between incurring a heart attack, suffering a stroke or diabetic crisis is related to deficiencies involving a body's metabolism of glucose and the ability to optimally conduct the...
|
|
|
US20090257950 |
Membrane Scaffold Proteins
The membrane scaffold proteins (MSP) of the present invention assemble with hydrophobic or partially hydrophobic proteins to form soluble nanoscale particles which preserve native structure and...
|
|
|
US20090253643 |
EQUOL LEVEL REGULATOR
An object of the invention is to provide a medical drug, a food and drink having a role in regulating the concentration of equal in vivo and being capable of taking for a long time with high safety...
|
|
|
US20090253642 |
MIMICKING THE METABOLIC EFFECTS OF CALORIC RESTRICTION BY ADMINISTRATION OF GLUCOSE ANTI-METABOLITES
Methods of maintaining and/or attenuating a decline in the quality of life of a mammal comprising the step of administering to the mammal a composition comprising an effective amount of...
|
|
|
US20090253613 |
Solid-Fluid Composition
A nanostructure comprising a core material of a nanometric size surrounded by an envelope of ordered fluid molecules is disclosed. The core material and the envelope of ordered fluid molecules are...
|
|
|
US20090252785 |
ENDOPLASMIC RETICULUM TARGETING LIPOSOMES
Provided are compositions that include lipid particles, such as liposomes, that can fuse with the ER membrane of a cell. The lipid particles can also deliver a cargo, such as a therapeutic or an...
|
|
|
US20090252672 |
NASAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS
The invention relates to a therapeutic composition comprising a therapeutically effective amount of one or more therapeutic agents and a nasal mucosa absorption-enhancing amount of one or more...
|
|
|
US20090247476 |
MANNITOL AND/OR PROLINE FOR PREVENTION AND TREATMENT OF AGEING RELATED SYMPTOMS
The current invention provides new methods and means for the prevention and treatment of ageing-related symptoms and diseases. The invention discloses mannitol 5 and/or proline containing...
|
|
|
US20090247475 |
METHODS AND COMPOSITIONS RELATING TO PHARMACOGENETICS OF DIFFERENT GENE VARIANTS IN THE CONTEXT OF IRINOTECAN-BASED THERAPIES
The present invention is directed to methods and compositions for determining the presence or absence of polymorphisms within an ABCC2, UGT1A1, and/or SLCO1B1 gene and correlating these...
|
|
|
US20090239812 |
USE OF C7 SUGARS IN PREVENTION AND TREATMENT OF MYCOSES
The object of the invention is use of at least one C7 sugar to make a composition intended for prevention and/or treatment of mycoses selected from among the group constituted of candidoses and...
|
|
|
US20090238780 |
Amla extract for transdermal application
An extract of Emblica officinalis (Amla). Transdermal formulation having an extract of Emblica officinalis having exhibiting greater migration of Vitamin C across a skin surface as compared to...
|
|
|
US20090233874 |
PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT
The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine...
|
|
|
US20090232750 |
Compositions for indoor tanning
Compositions for inducing a natural tan of the skin is disclosed. The compositions contain D-ribose as the active ingredient plus a penetrant to deliver D-ribose to the basal cells and dermis of...
|
|
|
US20090232735 |
USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER
The methods and compositions of the invention are based on the preferential utilization of fructose by cancer cells. This invention relates to compositions, methods and kits utilizing fructose and...
|
|
|
US20090227524 |
ANTIVIRAL THERAPEUTIC AGENTS
The invention provides compounds of Formula I:
as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for...
|
|
|
US20090227523 |
USE OF COMPATIBLE SOLUTES AS SUBSTANCES HAVING FREE RADICAL SCAVENGING PROPERTIES
Methods of using compatible solutes cyclic 2,3 -diphosphoglycerate (cDPG), 1, -di-glyccrol phosphate (DGP), firoin and firoin-A, and/or derivatives of these compounds or combinations thereof, for...
|
|
|
US20090226407 |
METHODS OF TREATING VASCULAR DISEASES CHARACTERIZED BY NITRIC OXIDE INSUFFICIENCY
The invention provides methods of treating and/or preventing vascular diseases characterized by nitric oxide insufficiency by administering a therapeutically effective amount of at least one...
|
|
|
US20090221515 |
MONOSACCHARIDE DERIVATIVES
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated...
|
|
|
US20090221469 |
USE OF SOY KEFIR POWDER FOR REDUCING PAIN, BLOOD PRESSURE AND INFLAMMATION
The present invention relates to a soy kefir powder produced by the fermentation of soy milk with Kefir grains of the Moscow strain under suitable fermentation conditions. The soy kefir powder of...
|
|
|
US20090220451 |
CYCLOPROPYL COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
US20090215718 |
CARBOHYDRATE COMPOSITION FOR FLAT GLUCOSE RESPONSE
A low-glycemic available carbohydrate composition of the invention contains the following components:
(i) 5-60 wt. % of one or more monosaccharides selected from monosaccharides other than glucose...
|
|
|
US20090214500 |
PREVENTION AND TREATMENT OF OSTEOCHONDROSIS IN ANIMALS AND HUMANS
The present invention relates to compositions and methods for preventing and treating osteochondrosis by administration of supplemental boron containing compounds to animals and humans. The...
|
|
|
US20090214419 |
SELF-ASSEMBLED BIODEGRADABLE POLYMERSOMES
The invention concerns a block copolymer of polyethylene oxide and polycaprolactone, the polyethylene oxide having a number average molecular weight from about 2.0 to about 3.8 kD, the block...
|
|
|
US20090209489 |
Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
In accordance with the present invention, there is to provide a dietary supplement that provides a mammal with the essential carbohydrates needed to maintain proper health and functionality, to...
|
|
|
US20090209487 |
Compositions of carbohydrates as dietary supplements
In accordance with the present invention, there is to provide a dietary supplement that provides a mammal with the essential carbohydrates needed to maintain proper health and functionality, to...
|
|
|
US20090209486 |
Compositions of carbohydrates as dietary supplements
In accordance with the present invention, there is to provide a dietary supplement that provides humans and animals with the essential carbohydrates needed to maintain proper health and...
|
|
|
US20090209474 |
NOVEL USES FOR DRUGS TARGETING GLUTAMINE SYNTHETASE
The present invention relates to novel therapeutic uses of tianeptine, salts, isomers, pro-drugs, metabolites and structural analogs thereof. Furthermore, the present invention relates to the use...
|
|
|
US20090208437 |
GLYCOPYRROLATE IN COSMETIC PREPARATIONS
Glycopyrronium bromide, derivatives and/or isomers thereof in combination with one or more active substances selected from a list of substances as recited in the claims and/or in the form of a W/Si...
|
|
|
US20090202508 |
NEGATIVE REGULATION OF HYPOXIA INDUCIBLE FACTOR 1 BY OS-9
The present invention discloses that OS-9 interacts with both HIF-1α and HIF-1α prolyl hydroxylases. Overexpression of OS-9 promotes the hydroxylation of HIF-1α, HIF-1α binding to VHL,...
|
|
|
US20090197820 |
Compositions and Methods for Improving Cardiovascular Health
Compositions and methods for improving cardiovascular health in the elderly by delivering a selection of essential amino acids, phytosterols, stanols, and isoflavones, which may be supplemented...
|
|
|
US20090197819 |
Compositions for improving and repairing skin
Compositions for improving the condition of the skin or for repairing damaged skin are disclosed. The compositions contain D-ribose as the active ingredient plus a penetrant to deliver D-ribose to...
|
|
|
US20090197818 |
Use Of Ribose for Recovery From Anaesthesia
D-Ribose is administered before and after general anaesthesia to reduce the time to recover from the effects of general anaesthesia. Preferably, pyrogen-free D-Ribose is administered intravenously...
|
|
|
US20090197796 |
Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at...
|
|
|
US20090186833 |
METHOD FOR PRODUCING PECTIN HYDROLYSIS PRODUCTS
Methods for the production of pectin hydrolysis products, the pectin hydrolysis products produced in this manner, as well as their use are described.
|
|
|
US20090181903 |
Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly
Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly by delivering a selection of amino acids, carnitine, and carboydrates with a low glycemic...
|
|
|
US20090181893 |
USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCE
The present invention provides compositions and methods for treating otic disorders. More specifically, the present invention describes the use of agents that down-regulate expression of Tanis...
|
|
|
US20090175968 |
DIETARY COMPOSITIONS FOR PROMOTING BRAIN HEALTH
Dietary compositions are disclosed herein. For example, dietary compositions containing a combination of a phosphatidylserine, DHA, EPA, antioxidants, and Ginkgo Biloba are provided.
|
|
|
US20090175957 |
ACIDIC COMPOSITION
A composition is provided which comprises an acidic component, generally fulvic acid, having a molecular weight not exceeding 20,000 Daltons and a low content of the elements aluminium, mercury,...
|
|
|
US20090175838 |
METHODS OF MODULATING IMMUNE FUNCTION
The invention relates to methods for modulating the immune function through targeting of CLIP molecules as well as gamma delta T-cells. The result is wide range of new therapeutic regimens for...
|
|
|
US20090169632 |
SUSTAINED RELEASE COMPOSITION AND MANUFACTURING METHOD THEREOF
A sustained release composition comprising a polymer and manufacturing method thereof. The sustained release composition comprises a polymer, a bioactive agent, and a release rate determined agent,...
|